GLS2 and neoplasm: The l-glutaminaseactivity, while apparently essential for complete antileukemic efficacyon tumor cells with significant asparagine synthetase expression,−,  is not required for anticancer activity against malignant cell lineageswithout asparagine synthetase expression. Nevertheless, the l-glutaminase activity is associatedwith several significant toxic side effects.